ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

HCK Is a Potential Mediator of Renal Fibrosis.

C. Wei,1 M. Menon,1 L. Li,2 Z. Yi,1 K. Keung,3 C. Woytovich,1 I. Greene,1 W. Zhang,1 J. He,1 B. Murphy.1

1Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
3Centre for Transplant and Renal Research, Westmead Millenium Institute, University of Sydney at Westmead Hospital, New South Wales, Australia.

Meeting: 2016 American Transplant Congress

Abstract number: D73

Keywords: Fibrosis, Nephropathy

Session Information

Session Name: Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection

Session Type: Poster Session

Date: Tuesday, June 14, 2016

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Background: Renal fibrosis is the consequence of excessive accumulation of extracellular matrix that occurs in patients with chronic kidney disease (CKD) and in kidney transplant recipients with chronic allograft nephropathy (CAN). Here, we identified a member of Src family of tyrosine kinases, HCK, up-regulated in allografts with CAN and studied its role in renal fibrosis.

Method: We used an integrative bio-informatics approach incorporating publically available data as well as data from the Genomics of allograft rejection study (GoCAR) to identify that the HCK network is up-regulated in CAN. In vitro over-expression/knock-down as well as HCK-inhibitor (Dasatinib) studies were performed to examine pro-fibrosis markers in tubular/fibroblast cell lines. To study the in vivo role of HCK in fibrosis, we performed unilateral-ureteric obstruction (UUO) on both PBS- or Dasatinib-treated mice.

Results: From bio-informatic metadata and GoCAR, HCK was identified as a key driver for allograft injury and CAN. In vitro, HCK over-expression activated SMAD-signaling in HEK-Blue TGF-b 293-T cells (which report SMAD-activity) while shRNA-mediated knock down inhibited TGF-b/Smad signaling. Next, HK2-cells treated with Dasatinib showed reduced COL1A1-expression, while rat fibroblasts (NRK-49F) showed reduced proliferation along with reduced α-SMA transcripts suggesting inhibited activation to myofibroblasts. In mice, Dasatinib-gavaged animals showed substantial down-regulation of inflammatory markers, like CCL3, CCL5 and TNFa at 3 days after UUO, compared to PBS-controls. At 7-days UUO, Col1A1, Fibronectin and Snail mRNA levels were inhibited and phosphorylation of SMAD3 was reduced in the UUO kidneys of dasatinib animals. By immunofluorescence, Col1A1 production was inhibited in UUO-kidneys upon Dasatinib-treatment. Renal interstitial fibrosis, measured by picrosirius red staining, was also significantly abrogated with dasatinib treatment (P<0.05).

Conclusion: HCK may be a potential mediator of kidney fibrosis in CAN via effects on inflammation, fibroblast cell proliferation, as well as direct effects on TGF-b signaling.

CITATION INFORMATION: Wei C, Menon M, Li L, Yi Z, Keung K, Woytovich C, Greene I, Zhang W, He J, Murphy B. HCK Is a Potential Mediator of Renal Fibrosis. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Wei C, Menon M, Li L, Yi Z, Keung K, Woytovich C, Greene I, Zhang W, He J, Murphy B. HCK Is a Potential Mediator of Renal Fibrosis. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/hck-is-a-potential-mediator-of-renal-fibrosis/. Accessed June 1, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences